Bull/Bear Index 46.6/100
→
crypto
BULL
45/10
TokenPost · 2h ago
BeiGene (ONC), 'BRUKINSA' Exceeds $1.1 Billion... FDA Approval and Priority Review Double Boost
Global oncology company BeiGene (ONC) is expanding its presence with strong sales of 'BRUKINSA' exceeding $1.1 billion, new drug approvals, and regulatory progress, alongside active investor relations.
Catch the next bull catalyst
Telegram alerts when our AI scores a story 8+/10 (~1-3 per day, no spam). Verified 30d hit rate 50.3%.
Join Telegram channel
or scan with phone →
